Description
Catalogue Number | IM096368 |
CAS No. | 138614-30-9 |
Alternate CAS No. | Deleted CAS: 148699-92-7 |
Chemical Name | Icatibant Acetate |
Synonyms | D-Arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-L-arginine Acetate Salt; D-Arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3aβ,7aβ)-octahydro-1H-indole-2-carbonyl-L-arginine Acetate Salt; Firazyr; HOE 140 |
Molecular Formula | C₅₉H₈₉N₁₉O₁₃S • xC ₂H₄O₂ |
Molecular Weight | 1304.54 + x(60.05) |
Appearance | White to Off-White Solid |
Melting Point | 213-218°C |
Storage | -20°C, Inert atmosphere |
Solubility | DMSO (Slightly), Water (Slightly) |
Applications | Icatibant Acetate is a bradykinin B2 receptor antagonist that has been recently approved for treatment of acute attacks of hereditary angioedema (HAE). |
Category | Standards; Amino Acids/Peptides; Pharmaceutical/API Drug Impurities/Metabolites; |
Note: All Products are stable to be shipped at room temperature, unless otherwise specified.